State Street Corp Capricor Therapeutics, Inc. Put Options Transaction History
State Street Corp
- $2.25 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CAPR
# of Institutions
70Shares Held
6.32MCall Options Held
210KPut Options Held
374K-
Black Rock Inc. New York, NY1.63MShares$35.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.55MShares$34.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA642KShares$14.1 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny480KShares$10.5 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ162KShares$3.57 Million0.0% of portfolio
About CAPRICOR THERAPEUTICS, INC.
- Ticker CAPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,346,200
- Market Cap $535M
- Description
- Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...